Evidence map›Paper›PMID 32444043›Full record

ArticleComplementary therapies in medicine2020

The effects of Moringa oleifera on blood glucose levels: A scoping review of the literature.

Frederick S Owens, Oluwabunmi Dada, John W Cyrus, Oreoluwa O Adedoyin, Georges Adunlin

Registry-linked trialAbstract readScoping Review
PubMed Publisher
In one paragraph

Article in Complementary therapies in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06125873 (Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients- an Interventional Study), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06125873 phase2unknown statusstarted 2023, after this paper: background citation

Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients- an Interventional Study

Ran2023Enrolled50Registered outcomes5Posted comparisons0ConditionsDiabetes Mellitus Type 2ArmsMetformin
Open the trial in the graph
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Life (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Article
  5. Effectiveness ofDiabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Frederick S OwensMcWhorter School of Pharmacy, Samford University, 800 Lakeshore Dr, Birmingham, AL 35229 USA. Electronic address: fowens@samford.edu.
Oluwabunmi DadaDepartment of Environmental Health Sciences, School of Public Health, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL 35233 USA. Electronic address: odada@uab.edu.
John W CyrusTompkins-McCaw Library, Virginia Commonwealth University, 509 N 12th St, Richmond, VA 23298-0430, USA. Electronic address: cyrusjw@vcu.edu.
Oreoluwa O AdedoyinShoreland Inc., 100 Centerview Drive, Suite 200, Birmingham, AL 35216, USA. Electronic address: oadedoyin@shoreland.com.
Georges AdunlinMcWhorter School of Pharmacy, Samford University, 800 Lakeshore Dr, Birmingham, AL 35229 USA. Electronic address: gadunlin@samford.edu.
Samford University · USLakeshore Foundation · USUniversity of Alabama at Birmingham · USVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is an increasingly problematic health concern in the United States. Moringa oleifera (M. oleifera) has been suggested as medication in the prevention or treatment of diabetes, but there is no convincing evidence of a causal relation between moringa and decreased blood sugar levels in humans. The purpose of this scoping review is to examine the effects of Moringa oleifera on blood glucose levels in rats and humans. A search of Scopus, Ovid Medline, Ovid Embase, IPA, and Web of Science and manual searching of bibliographies were performed for peer-reviewed English articles published between May 1, 2008 and May 1, 2018. This review included thirty studies. Out of seven human studies, five found that M. oleifera significantly reduced blood glucose levels in diabetic patients. Out of twenty-three animal studies, twenty-one found that administration of M. oleifera led to a statistically significant decrease in animal blood glucose levels. In human studies, moringa was mostly administered in a powdered leaf form, while in animal studies it was frequently administered to as an aqueous or ethanol-based extract. The review found statistical evidence that moringa decreased blood glucose; the evidence is not strong enough to recommend it as the default treatment for people with diabetes.

Indexed as

AnimalsBlood GlucoseHumansMoringa oleiferaPlant ExtractsPlant LeavesRatsBlood GlucosePlant ExtractsAntidiabeticAqueousBlood glucoseEthanolMoringa oleifera

Identifiers

PMID32444043
OpenAlexW3008472652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.